مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer.
Normal view MARC view ISBD view

XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer. [electronic resource]

By:
  • Cereda, Stefano
Contributor(s):
  • Reni, Michele
  • Rognone, Alessia
  • Ghidini, Michele
  • Belli, Carmen
  • Longoni, Simona
  • Fugazza, Clara
  • Brioschi, Matteo
  • Nicoletti, Roberto
  • Balzano, Gianpaolo
  • Passoni, Paolo
  • Villa, Eugenio
Producer: 20110118Description: 4785-90 p. digitalISSN:
  • 1791-7530
Subject(s):
  • Adenocarcinoma -- drug therapy
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
  • Camptothecin -- administration & dosage
  • Capecitabine
  • Deoxycytidine -- administration & dosage
  • Female
  • Fluorouracil -- administration & dosage
  • Humans
  • Irinotecan
  • Leucovorin -- administration & dosage
  • Middle Aged
  • Neoplasm Metastasis
  • Pancreatic Neoplasms -- drug therapy
  • Salvage Therapy
  • Survival Rate
  • Treatment Outcome
  • Young Adult
  • Gemcitabine
In: Anticancer research vol. 30
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer.

APA

Cereda S., Reni M., Rognone A., Ghidini M., Belli C., Longoni S., Fugazza C., Brioschi M., Nicoletti R., Balzano G., Passoni P. & Villa E. (20110118). XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer. : Anticancer research.

Chicago

Cereda Stefano, Reni Michele, Rognone Alessia, Ghidini Michele, Belli Carmen, Longoni Simona, Fugazza Clara, Brioschi Matteo, Nicoletti Roberto, Balzano Gianpaolo, Passoni Paolo and Villa Eugenio. 20110118. XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer. : Anticancer research.

Harvard

Cereda S., Reni M., Rognone A., Ghidini M., Belli C., Longoni S., Fugazza C., Brioschi M., Nicoletti R., Balzano G., Passoni P. and Villa E. (20110118). XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer. : Anticancer research.

MLA

Cereda Stefano, Reni Michele, Rognone Alessia, Ghidini Michele, Belli Carmen, Longoni Simona, Fugazza Clara, Brioschi Matteo, Nicoletti Roberto, Balzano Gianpaolo, Passoni Paolo and Villa Eugenio. XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer. : Anticancer research. 20110118.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site